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New Zealand Black (NZB) X New Zealand White (NZW)F, hybrid mice exhibit
a markedly different autoimmune process compared with that seen in the
parental NZB or NZW strains. The F, disease is characterized by the production
of antinuclear antibodies and a fatal immune-complex glomerulonephritis, fea-
tures similar to those observed in human systemic lupus erythematosus (SLE)'
(1). Unlike the parental strains, (NZB X NZW)F, mice develop markedly elevated
serum levels of IgG antibodies to histones (2) and double-stranded DNA (dsDNA)
(3-6), of which the latter has been causally linked to the renal disease (3, 7-9).
Female mice develop an earlier switch from IgM to IgG autoantibodies and an
earlier and more severe renal disease compared with their male counterparts (1,
4, 5). Most female F, mice die from disease within the first year of life. In
contrast, parental NZB mice develop an autoimmune hemolytic anemia as the
major feature of their autoimmune disease (1). Renal disease is usually mild and
rarely is clinically manifest before I yr of age. NZB mice frequently produce
IgM antinuclear antibodies and occasionally produce IgG antibodies to single-
stranded DNA (ssDNA); however, high levels of IgG antibodies to dsDNA or
histones are unusual (6) . Although NZW mice may produce antibodies to ssDNA,
this strain rarely demonstrates clinical evidence of autoimmune disease during
the first 18 mo of life (1, 10-12) .
Since the major features of (NZB X NZW)F, autoimmune disease are not
present in the parental strains, genes from each parent most likely act in concert
to produce the F, phenotype. While it has been hypothesized (13-15) that a
gene or genes in the NZW background accelerate and worsen the mild lupus-
like autoimmunity of NZB mice, the precise nature of the NZW genetic contri-
bution to (NZB X NZW)F, disease remains unclear. Results from previous
backcross studies (6, 11, 16) have been difficult to interpret in terms of the
number of involved NZW genes, although one dominant gene appears to be
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linked to the H-2z locus. As noted above, the switch from IgM autoantibodies
(an NZB-like trait) to IgG autoantibodies in F, hybrids has suggested an NZW
influence on T cell function, and T cells of the L3T4 subset appear to be
required for IgG anti-dsDNA antibody production in F, mice (17). We and
others (18, 19) recently identified an unusual allele of the T cell receptor 0 chain
gene complex in NZW mice that is distinguished by the deletion of 8 .8-kb of
DNA containing the Cpl, 13,32, and Jp2 gene segments. In more recent studies,
we have investigated T cell receptor a chain genes in NZW mice. Examination
of genomic DNA with probes specific for different a chain variable gene families
revealed multiple restriction fragment length polymorphisms compared with
NZB and many nonautoimmune strains (Kotzin, B. L ., V. Appel, and E. Palmer,
unpublished observations).
Thus, at least three unlinked genetic loci have been distinguished in NZW
mice that conceivably contribute to T cell dependent autoantibody responses in
(NZB X NZW)F, mice. These include the T cell receptor a and # chain loci
described above as well as the unusual MHC haplotype in NZW (H-2z, reference
20). We undertook an (NZB X NZW)F, X NZB backcross to determine the
relative contribution of these NZW genes to lupus-like renal disease and autoan-
tibody production in the F, . We now report a strong correlation between the
presence of the H-2z haplotype and lupus-like disease in backcross mice. This
MHC or gene(s) linked to this locus appears to be the only dominant NZW
genetic contribution to F, disease, and there appears to be no association between
the presence of NZW T cell receptor alleles and autoimmune disease.
Materials and Methods
Mice.
￿
Parental NZB and NZW mice, BALB/c, and C57BL/6 mice were obtained from
the NCI Frederick Cancer Research Center, Fort Detrick, Frederick, MD. (NZB X
NZW)F, hybrids and (NZB X NZW)F, X NZB backcross mice were bred in the animal
facilities of the V. A. Medical Center, Denver, CO. Only female animals were used for
the present experiments. All groups of mice were housed in the same animal room, fed
the same diet, and analyzed concurrently. At the beginning of the study, 178 backcross
mice (mean age, 4 mo) were randomized to be followed until 12 mo of age. Four of these
mice died of unknown causes before 11 mo of age with no evidence of proteinuria, and
were excluded from the analysis. Before 12 mo ofage, severely ill animals were killed for
collection of tissues. At 12 mo of age, all backcross mice were killed.
Collection ofSerum and Tissue Samples.
￿
Experimental mice were usually bled at monthly
intervals beginning at 6 mo of age. Blood was obtained from the retroorbital sinus, clotted
at room temperature, and the serum was stored at -20°C until further use. Liver and
kidneys were obtained from killed mice and then frozen at -70'C until further use.
Proteinuria. Proteinuria was measured with tetrabromphenol paper (21) on freshly
collected urine samples. This colorimetric assay, which is relatively specific for albumin,
was graded 1-4+ and approximated protein concentrations were as follows: 1+, ^-30 mg%;
2+ , ^-100 mg% ; 3+, ^-300 mg% ; and 4+, 2:1,000 mg%. Mice with negative or trace
determinations at 12 mo of age were classified as having no evidence of renal disease.
Severe proteinuria was defined as >2+ (>100 mg%). In previous studies (21, 22), mice
with this level of proteinuria usually died from renal failure within a period of 4-8 wk.
Southern Analysis of Genomic DNA.
￿
Liver and kidney DNA from individual mice were
isolated as described (23). DNA was then digested with the restriction enzyme Pvu II (2
U/fag DNA for 1 h at 37°C); this procedure was repeated once. Digested DNAs were
subjected to electrophoresis through 0.7% agarose gels, transferred to nitrocellulose
filters, and hybridized with a 32P-labeled probe as described (24), except that the acidKOTZIN AND PALMER
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purination step was omitted and the gel was irradiated for 7 min with shortwave UV light
before denaturation (18). Filters were washed several times in 2X SSC (1 X SSC: 0.15 M
NaCI, 0.015 M sodium citrate) at room temperature and once in 0.IX SSC at 55° C for
35 min. Hybridizing fragments were detected by autoradiography. A cDNA probe (pH-
211A) derived from the 3' untranslated exon of a class I MHC gene (kindly provided by
Dr. L. Hood) was used to identify MHC haplotypes (25). This probe hybridizes to multiple
class I genes within the MHC of all strains tested. The T cell receptor a chain allele was
identified using a cDNA clone (V, 7.2) containing V., J., and C. gene sequences (Yague,
J., M. Blackman, W. Born, P. Marrack, J. Kappler, and E. Palmer, manuscript submitted
for publication). The V. 7 .2 sequence falls into a previously identified V. multi-gene
family (26). The T cell receptor # chain allele was identified with a CO probe, pDOa2,
derived from a C#2 cDNA clone (18, 27). This probe hybridizes to restriction fragments
containing Csl and Cs2 sequences.
Measurement of Antihistone and Anti-DNA Antibodies.
￿
Antibodies to histones, ssDNA,
and dsDNA were quantitated using an ELISA as described previously (2, 22, 28, 29). To
measure antihistone antibody activity, total histories were obtained by acid extraction of
calf thymus chromatin, diluted in PBS to a concentration of 2.5 Ag/ml and then 0.2 ml
of antigen solution were added per well of an Immulon II microtiter plate (Dynatech
Laboratories, Inc., Alexandria, VA). Afterovernight incubation at 4° C, wells were coated
with 0.2 ml gelatin ( 1 mg/ml in PBS) for at least 16 h at VC. C. Control wells were coated
with gelatin only. After washing, 0.2 ml of sera that were diluted 1/500 to 1/2,000 in
PBS-Tween with 5 mg/ml bovine .y-globulin and I mg/ml gelatin were added and
incubated for at least 1 .5 h at room temperature. After washing, peroxidase-coupled
antibodies to mouse IgM or to mouse IgG (both from Kirkegaard and Perry Laboratories,
Inc., Gaithersburg, MD) were added at saturation levels. After 2 h incubation at room
temperature, the wells were washed with PBS-Tween and substrate solution was added.
The optical density (OD) was then read at various times thereafter with an automated
spectrophotometer (Dynatech Laboratories, Inc.) at 405 nM. All samples were run in
triplicate and standard positive and negative control serum samples were run on each
ELISA plate. OD values were converted to units of antibody activity (described below).
Antibodies to ssDNA were measured similarly, except that heat-denatured DNA was
initially coated to wells at 2 .5 /Ag/ml (28, 29). dsDNA was extracted from mouse liver as
described (23) and stored at 4°C for no greater than 1 wk before use in the ELISA assay.
To successfully attach dsDNA, microtiter wells were first coated with poly-D-lysine (Sigma
Chemical Co., St. Louis, MO) at 5.0 ug/ml in H2O overnight at 4°C. After washing,
dsDNA was added at 5.0 kg/ml in PBS for ^-20 h. Wells were then washed in PBS and
then incubated with 5 U/ml sodium heparin diluted in PBS-Tween for 1 h at 20°C. After
washing, sera or standards were added as described above. We have demonstrated
previously that mAbs specific for histone do not crossreact with DNA in these assays and
vice versa (28). In the current study, nearly halfof the (NZB X NZW)F, X NZB backcross
mice were negative for antibodies to dsDNA or histories, yet nearly all had markedly
elevated antibodies to ssDNA. Thus, this assay for anti-dsDNA antibodies demonstrates
very low sensitivity for antibodies to ssDNA.
To allow for interassay comparisons, OD values were converted to a unit scale using
antihistone and anti-DNA mAbs described in a previous report (28). Known concentra-
tions of purified mAbs were run with every assay to create a standard curve. OD values
from sera were then converted to a unit scale; one unit was defined as that level of
antibody activity observed with 1 /Ag/ml of the appropriate mAb.
Results
Expression of Renal Disease in (NZB X NZW)FI X NZB Backcross Mice.
￿
To
determine the contribution of NZW genes to (NZB X NZW)F1 autoimmune
disease, (NZB X NZW)F, X NZB backcross mice were bred and then analyzed
for expression of lupus-like renal disease. Because of the known influence of sex
on disease (1, 4, 5), only female backcross, F 1 (NZB X NZW), and parental (NZB1240
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Expression of severe proteinuria in (NZB X NZW)F, X NZB backcross, (NZB X
NZW)F,, NZB, and NZW mice. All mice were female, housed in the same area, andanalyzed
concurrently. Severe proteinuria was defined as >2+ (>100 mg%) by spot urine colorimetric
analysis (21, 22).
and NZW mice) were used for analysis. Fig. 1 shows the percentage of each
group that developed severe proteinuria over 12 mo. Beginning at 5-6 mo of
age, the percentage of F, and backcross mice demonstrating severe proteinuria
progressively increased. At 11 mo of age, 95% of F, and 45% of backcross mice
had developed severe proteinuria. Nearly all of these mice died within 4-6 wk
of the initial detection of severe proteinuria, presumably from renal failure (21).
At 12 mo of age, 84 of 174 backcross mice (48%) demonstrated evidence of
severe renal disease. In contrast to F, and backcross mice, parental NZB and
NZW mice showed a very low incidence of severe proteinuria throughout the
observation period. At 11 mo of age, only one NZW (3%) and two NZB (4%)
were positive for severe proteinuria, and no parental animal died before 12 mo
of age. Thus the incidence of renal disease in the backcross mice was approxi-
mately half of that observed in (NZB X NZW)F, mice, suggesting that a single
NZW locus contributes to the F, renal disease.
Production ofIgG Antinuclear Antibodies in Backcross Mice.
￿
Beginning at 6 mo
of age, backcross and parental mice were serially bled and the sera were analyzed
for IgG and IgM antibodies to ssDNA, dsDNA, and histories. NZW, NZB, and
nearly all backcross mice had markedly elevated peak IgG anti-ssDNA antibody
levels (data not shown) and thus this autoantibody could not be used to discrim-
inate parental from F, disease. IgM antibodies to all three antigens were also
frequently present in NZB mice. In contrast, no nonautoimmune mice and only
rare parental NZB or NZW mice demonstrated elevated levels of IgG anti-
dsDNA or antihistone antibodies (Fig. 2). The data are presented as peak values1241
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FIGURE 2.
￿
Serum levels of IgG antihistone and anti-dsDNA antibody levels in backcross,
NZB, NZW, and nonautoimmune (BALB/c and C57BL/6) mice. (A) For antihistone antibody
values,the number at the bottom of thecolumn indicates the number ofmice with levels 55_0.5
U. IgGantihistone antibody levels (mean ±SE) were 6.60 t 0.86, 0.36 t 0.24, 1.6 ± 1.4, and
0.10 ± 0.04 for backcross, NZB, NZW, and nonautoimmune mice, respectively. (B) Foranti-
dsDNA antibody values, the number at the bottom of the column indicates the number of
mice with levels 553.0 U. Anti-dsDNA antibody levels (mean ± SE) were 9.9 ± 1.2, 0.70 ±
0.32, 1.84 t 1.53, and 0.28 ± 0.11 for backcross, NZB, NZW, and nonautoimmune mice,
respectively. All values represent the peak levels for individual mice between 6 and 11 mo of
age.
for individual mice determined between 6 and 11 mo ofage. Whereas only 4%
of NZB and 6% of NZW mice had IgG antihistone antibody levels >2 U, 42%
ofbackcross mice had at least this level. In a similar analysis, 4% ofNZB and 3%
of NZW mice had IgG anti-dsDNA antibody levels >5 U; in contrast, 47% of
the backcross mice had peak values >5 U. These threshold values to categorize
mice with elevated levels were determined arbitrarily. However, similar percent-
ages were obtained using a cutoff of 4 SD above the mean level for nonautoim-
mune mice. Although not measured concurrently, nearly all (NZB X NZW)F,
mice routinely developed elevated levels of these autoantibodies in previous
analyses (2, 21, 22). Thus, excessive production of these IgG lupus-?ike antinu-
clear antibodies in approximately half ofthe backcross mice also suggests that a
single NZW genetic locus contributes to F, autoantibody production.
Similar to (NZB X NZW)F, mice (2, 21, 22), diseased backcross mice usually
demonstrated peak levels of IgG anti-dsDNA or antihistone antibodies at ^"8-9
mo ofage, and theelevated levels werecomparable between the F, and backcross
groups (data not shown). A high correlation (>0.9) was observed between
JA ;.
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FIGURE 3 .
￿
Southern analysis ofliverDNA from NZB, NZW, and (NZB X NZW)F, mice . All
samples were digested with Pvu II . (Vo 7.2) Blots were hybridized with acDNA probe, Vo 7.2,
which recognizes a multigene family of murine T cell receptor Va genes . (CO) Blots were
hybridized with a C # probe, pDO#2, derived from a C#2 cDNA clone, which identifies
restriction fragments containing C#1 and Cy2 (18, 27) . There are actually two Crcontaining
restriction fragments (6.0 and 6.2 kb) in the Pvu II digests ofNZB DNA (18) . (MHC) Blots
were hybridized with a cDNA probe (pH-211A) derived from the 3' untranslated exon of a
class I MHC gene (25) . This probe hybridizes to multiple class I genes within the MHC.
elevated levels of these autoantibodies and the expression of renal disease in
backcross mice .
Correlation of Genotype with the Expression of Renal Disease in Backcross
Mice . For any genetic locus, (NZB X NZW)FI X NZB backcross mice are either
heterozygous for the NZW allele (as in [NZB X NZW]FI mice) or homozygous
for the NZB allele. We attempted to correlate the genotype of individual
backcross mice with the expression of lupus-like autoimmune disease . The
genotypes for the MHC, T cell receptor a chain, andT cell receptor ,Q chain loci
in individual mice were determined by Southern analysis of genomic liverDNA .
Fig . 3 shows the restriction fragment length polymorphisms used to distinguish
NZB, NZW, and FI DNA for these three loci . AT cell receptor a chain cDNA
containing the Va 7.2 gene segment (Yague, J., M. Blackman, W . Born, P.
Marrack, J . Kappler, and E. Palmer, manuscript submitted for publication)
hybridized to a 2.5-kb fragment in Pvu 11 digests of NZW DNA that was not
present in similarly digested NZB DNA. To identify the NZW T cell receptor ,0
chain allele, a C, 3probe (pDO02) was used that hybridizes to restriction fragments
containing C, 31 andC#2 (18, 27) . Thereare actually twoCo-containing restrictionV
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FIGURE 4.
￿
Analysis of genotype in backcross mice with severe renaldisease before 10 mo of
age (n = 47) and in backcross mice with no evidence of renal disease when killed at 12 mo of
age (n = 45). The data are presented as percentage of mice heterozygous for the NZW H-2'
haplotype, NZW T cell receptor a chain allele or NZWT cell receptor #chain allele.
fragments (6.0 and 6.2 kb) in the Pvu II digests of NZB DNA that are not
resolved. The NZW 5.0-kb fragment containing only C,#2 is easily distinguished
from the larger NZB fragments in the heterozygous F, or backcross mice. The
probe, pH-211A, used to identify the H-2 region hybridizes to multiple class I
loci within the MHC of all mice tested (Hood, L., personal communication,
reference 25). Two Pvu II restriction fragments (4.1 and 1.8 kb) are present in
NZW (H-2z) but not in NZB (H-2d) DNA and could be used to identify the NZW
allele in backcross mice heterozygous at the MHC.
For genetic analysis, we randomly selected 47 backcross mice that expressed
severe proteinuria at or before 10 mo ofage and subsequently died from disease.
The incidence of severe renal disease in parental NZB mice at 10 mo was 2%
and no NZB deaths were recorded during the observation period (see Fig. 1).
We also obtained DNA from a similar number of randomly selected backcross
mice that showed no evidence ofproteinuria (negative or trace by colorimetric
analysis) when killed at 12 mo of age. Overall, in these 92 backcross mice, 53%,
57%, and 48% were heterozygous at the NZW MHC, T cell receptor a chain
locus, and T cell receptor Q chain locus, respectively. This is close to the expected
incidence of 50% for randomly assorting alleles.
The data in Fig. 4 compare backcross mice with and without renal disease. In
backcross mice with severe renal disease, 89% carried the NZW MHC haplotype,
i.e., these mice were H-2d1' heterozygotes (p < 0.0001 by X2 analysis compared
with overall 53% frequency of H-2dl,). In mice with no evidence ofdisease, only
15.5% were H-2diz heterozygotes (p < 0.0001 compared with overall frequency).
Thusa gene or complex ofgenes linked to the NZW MHC appears to be strongly
associated with disease expression. Nevertheless, the association was not perfect,
in that 11 % of the diseased mice did not carry the H-2Z haplotype. In contrast,
there was no association between the presence of the NZW a chain or /3 chain
alleles and the expression of disease. Whereas 57% of diseased backcross mice
carried the NZW allele of the T cell receptor a chain locus, 56% of backcross
mice without disease carried this allele. There was also no association of autoim-1244
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￿
Expression of severe renal disease with age in 92 backcross mice grouped by
genotype. The data are presented as the percentage of mice with severe proteinuria. There
were 49, 52, and44 mice heterozygous for the NZW H-2` haplotype, NZW T cell receptor a
chain locus (a"'), and NZWT cell receptor0 chain locus (0"), respectively.
mune disease with the NZWachain locus. Indeed, only 40% ofmice with disease
carried this allele compared with 56% of the backcross mice without disease.
Particular genotypes were also examined for correlations with the expression
of severe proteinuria. As shown in Fig. 5, backcross mice with the NZW H-2z
haplotype demonstrated a progressive increase in the incidence ofdisease during
the observation period . At 10 mo ofage, 86% of the H-2di, mice had expressed
severe proteinuria compared with 12% ofthe H-2d1d mice (p < 0.0001). It should
be noted that the disease in these five H-2d1d mice was indistinguishable from
that in the H-2df mice. In contrast to H-2z, no significant difference in disease
expression was apparent in mice heterozygous for the NZW T cell receptor a
chain locus compared with those homozygous for the NZB allele (52 vs. 50% at
10 mo). Mice with the NZW ,Q chain allele actually showed a slightly lower
incidence of renal disease compared with those homozygous for the NZB allele
(43 vs. 58%).
Correlation of Genotype with the Production of IgG Antinuclear Antibodies in
Backcross Mice. We also were able to correlate the genotype of the backcross
mice with the production of IgG antihistone and anti-dsDNA antibodies. Fig. 6
shows that the only difference in mean serum levels of antihistone antibodies
exists when H-2d1z mice are compared with H-2dld mice (mean ± SE, 11.9 ± 1.52
for H-2diz mice vs. 1.72 ± 0.81 for H-2d1d mice, p < 0.001, as shown by the
Wilcoxon rank sum test). Similar to percentages observed for development of
proteinuria, 88% of animals with serum levels >2 U were H-2diz while 12% of
the mice homozygous for H-2d demonstrated this degree ofelevation (compared
with 4% of NZB mice ; see Fig. 2). The presence of either NZW T cell receptor
allele was not predictive ofcirculating IgG antihistone antibody levels.
Nearly identical results were obtained for IgG anti-dsDNA antibody levels
(Fig. 7). Alarge difference in mean serum levels was apparent when comparing
H-2d/, with H-2d/' backcross mice (15.8 ± 1.47 for H-2d/, mice vs. 5.48 ± 1.76
for H-2d/d mice, p < 0.001). Using 5 U of IgG anti-dsDNA activity as a cutoff,
86% of mice with elevated levels were H-2d/,. In contrast, 16% of the mice
homozygous for H-2d demonstrated elevated levels oftheseantibodies comparedKOTZIN AND PALMER
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￿
Levels of IgG antihistone antibody activity in the sera of backcross mice with
different genotypes. Each point represents the peak level for an individual animal measured
between 6 and I I mo of age. The lines indicate the mean level for the different groups of
mice.
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￿
Levels of IgG anti-dsDNA antibody activity in the sera of backcross mice with
different genotypes. Each point represents the peak level for an individual animal measured
between 6 and 1 I mo of age. The lines indicate the mean level for the different groups of
mice.
with 4% of parental NZB mice (see Fig. 2). Again, the levels of these autoanti-
bodies could not be correlated with a chain ora chain genotypes.
Correlation of Genotype with, the Production of IgM Anti-dsDNA Antibodies in
Backcross Mice. We also determined whether the presence ofany of these three
NZW loci influenced the production of IgM anti-dsDNA antibodies in backcross
mice. Fig. 8 shows that in contrast to IgG anti-dsDNA antibodies, IgM antibody1246
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FIGURE 8.
￿
Levels of IgM anti-dsDNA antibody activity in the sera of backcross mice with
different genotypes. Each point represents the peak level foran individual animal measured
between 6 and I I mo of age. The lines indicate the mean level for the different groups of
mice.
levels were not influenced by the H-2 genotype. Thus, both H-2dl' and H-2d/d
backcross mice had similar serum IgM anti-dsDNA antibody levels (mean ± SE,
13.1 ± 1 .1 U for H-2d/, mice vs. 13.9 ± 1.8 U for H-2d1d mice). No difference
was detected when mice heterozygous for the NZW a chain allele were compared
with those homozygous for the NZB allele. Mice carrying the NZW allele for the
T cell receptor # chain locus showed a small decrease in mean IgM anti-dsDNA
activity (11 .2 ± 1 .2 U vs. 15.5 ± 1.6 U in mice homozygous for the NZB allele,
p = 0.05 by Student's ttest). This difference was much smaller than that observed
for the influence of H-2 genotype on IgG antinuclear antibodies.
The data from this backcross strongly suggest that one dominant gene or
closely linked group of genes accounts for the NZW contribution to (NZB x
NZW)F, lupus-like disease. Approximately halfof the backcross mice expressed
severe renal disease at an age when 95% of the F, mice and <5% of parental
mice were similarly affected. Although the distinction between positive and
negative is not as clear-cut, a similar percentage ofbackcross mice produced IgG
anti-dsDNA and antihistone antibodies, autoantibodies that are characteristic of
F, but not parental mice. ^-40-50% of backcross mice demonstrated elevated
levels for both autoantibodies compared with <5% for NZB mice. The correla-
tion ofgenotype with expression ofdisease also supports a single-dominant-gene
hypothesis. Thus, 86% of H-2diz mice expressed early and severe proteinuria. If
two or more unlinked NZW genes are required, one would expect <50% of
mice with any particular allele and <25% of the total backcross mice to express
disease. Similarly, 90-95% and 75-80% of H-2d17 mice had elevated levels of
IgG anti-dsDNA and antihistone antibodies, respectively. The high expression
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of disease in H-2diz mice is even more impressive when one considers the
incomplete expression ofdisease in F, mice (95%) and the inexact correlation of
the H-2z allele with disease (see below).
Previous studies (6, 11, 16) of (NZB X NZW)F, X NZB backcross mice have
suggested that one or two dominant NZW genes contribute to the incidence and
severity of lupus-like renal disease. Interestingly, in studies (6, 11) suggesting a
single NZW genetic contribution to expression of proteinuria, two genes ap-
peared to be involved in anti-dsDNA antibody production. In contrast, we found
an extremely high correlation between expression of renal disease, IgG anti-
dsDNA, and IgG antihistone antibody production. Thus, in the present study,
one NZW gene appears to influence all of these traits. We cannot exclude,
however, that each trait is controlled by different but closely linked loci. The
reason for the discrepancy among these analyses is unclear. It is known that
environmental influences such as viral infections, stress, and diet can influence
the incidence and severity of disease in (NZB X NZW)F, mice (30-35). It is
conceivable that these factors can override therequirement fora particular gene.
Serologic evidence of murine hepatitis virus has been detected intermittently in
our animal facility as it has recently in many facilities around the country.
However, the kinetics of F, disease expression and autoantibody production in
our breeding facility have been fairly constant for the last 5 yr and are similar to
that previously observed in another facility (21).
We and others previously described (18, 19) a distinctly unusual Tcell receptor
,Q chain allele in NZW mice, characterized by the deletion ofC'31, D'32, andJ32
gene segments. No other mammal studied thus far has been noted to have lost
the duplication of 0 chain gene segments. Despite the unusual nature of this
gene complex in an animal known to contribute genes to autoimmune disease,
we found no association ofdisease expression with the presence of this allele in
the backcross mice. The incidence of proteinuria as well as serum levels of
autoantibodies were actually slightly higher in mice homozygous for the NZB
allele. Using a similarly designed backcross study, Yanagi et al. (36) recently
reported that the presence of the NZW ,B chain locus was associated with
increased levels of IgG anti-DNA antibodies and gp70 immune complexes. This
has not been confirmed in the present work and the reason for the difference in
results is unknown. It is difficult to envision how a deletion of T cell receptora
chain gene segmentsbehaves dominantly in an F, animal to account for enhanced
autoantibody production. We are currently carrying out crosses to test whether
the deletion of 0 chain gene segments in NZW mice offers protection in some
way from certain types of autoantibody production. It is conceivable that the
addition of new NZB T cell receptor gene segments (i.e., 13,32, J02) in F, mice
might influence the expression ofautoimmune disease.
We also found no association of disease expression with the NZW T cell
receptor a chain allele. NZW Va genes are polymorphic in that several probes
specific for different Va families reveal restriction fragment length polymor-
phisms in NZW mice that are not seen in NZB or other nonautoimmune strains
(Kotzin, B. L., V. Barr, and E. Palmer, unpublished observations). It is notewor-
thy that NZW mice carry rare T cell receptor a and ,0 chain alleles, as well as an
unusual MHC hapiotype. It should be emphasized that the NZW strain was1248
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developed separately from other New Zealand strains (37), and therefore, the
presence of unusual alleles in NZW but not in NZB mice is not surprising.
We found a strong but imperfect correlation between the expression oflupus-
like disease and the presence of the NZW H-22 haplotype. Of the mice that
developed severe proteinuria, ~90% were heterozygous (H-2dl'). Furthermore,
12% of the homozygous H-2d mice developed severe renal disease. Similar
correlations were observed for IgG but not for IgM antinuclear antibody pro-
duction. This association with MHC-linked genes is consistent with previous
studies in which backcross mice were phenotyped using anti-H-2 antisera (6, 11,
15). Our data were obtained using a probe that recognizes multiple class I genes
that are all encoded within the MHC (reference 25 and Hood, L., personal
communication). Although the chromosomal positions ofthe genes correspond-
ing to thepolymorphic NZW bands that were used for MHC typing are unknown,
these genes must be tightly linked (51.5 cM) to the MHC H-2K, la region, and
H-2D genes. In recent work using a probe specific for the I-A a chain gene, we
have confirmed (without a single exception) the H-2 genotype of the diseased
backcross mice (Kotzin, B. L., and E. Palmer, unpublished observations).
A surprising feature of the present study is the frequency of discordance
between the autoimmune phenotype and the presence of H-2Z. Assuming that
the NZW gene controlling disease expression behaves in a Mendelian fashion,
there is an apparent recombination rate between this gene and the MHC of
-10%. Although it is easy to believe that the disease gene lies within H-2, our
results suggest that this gene may be located ~10 cM away from the MHC. It is
difficult to discount this conclusion on the basis of incomplete penetrance since
14% ofthe H-2'1z backcross mice failed to develop severe disease compared with
only 5% of F, mice. Furthermore, a background effect seems an unlikely
explanation because 12% of H-2d1d backcross mice expressed severe renal disease
compared with only 2% of similarly aged NZB mice. Still, a rare NZB (H-2did)
animal can develop severe lupus-like autoimmune disease and this low level of
expression might be modified by a combination of non-H-2-linked genes from
the NZW. We are currently attemptingto define the position of the disease gene
using genomic DNA from these backcross mice and DNA probes located 5-10
cM centromeric and telomeric to the MHC.
Summary
Unlike parental NZB or NZW mice, (NZB X NZW)F, mice exhibit a lupus-
like disease characterized by high serum levels ofIgG antinuclear antibodies and
a fatal immune-complex glomerulonephritis. At least three unlinked gene loci
can be distinguished in NZW mice that conceivably contribute to a T cell-
dependent autoimmune disease, including the MHC (H-2Z) and the T cell
receptor a and ,Q chain gene complexes. We undertook an (NZB X NZW)F, X
NZB backcross to determine the relative contribution of these NZW genes to
lupus-like renal disease and autoantibody production in F, mice. The incidence
of severe renal disease and elevated levels of IgG antibodies to dsDNA and
histone in the backcross mice was approximately half of that observed in (NZB
X NZW)F, mice. Furthermore, there was a strong correlation between the
presence of the NZW H-2z haplotype and lupus-like disease in backcross mice.^-90% of backcross mice with disease carried the NZW H-2Z locus compared
with 16% of mice without disease; nearly 90% of H-2diz mice expressed severe
autoimmune disease. In contrast, no association was apparent between the
presence of the NZW T cell receptor a chain gene complex or # chain gene
complex and severe renal disease or autoantibody production. Thus, the NZW
MHC or gene(s) linked to this locus appear to be the only dominant NZW genetic
contribution to F, disease.
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